| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $0 ) |
| | 2026 | 2021 | INTERVENTIONAL ANALGESIX INC. | 701 W MAIN ST | DURHAM | NC | 27701-5012 | DURHAM | USA | R44NS120840 | Analgesic Drug for Local Delivery by Fluoroscopy | 000 | 2 | NIH | 3/20/2026 | $0 |
| | 2026 | 2021 | INTERVENTIONAL ANALGESIX INC. | 701 W MAIN ST | DURHAM | NC | 27701-5012 | DURHAM | USA | R44NS120840 | Analgesic Drug for Local Delivery by Fluoroscopy | 001 | 2 | NIH | 3/27/2026 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2021 | INTERVENTIONAL ANALGESIX INC. | 701 W MAIN ST | DURHAM | NC | 27701-5012 | DURHAM | USA | R01NS100725 | Intraganglionic Analgesic Adeno-Associated Virus (AAV) Gene Vector Optimization in Large Animals | 000 | 5 | NIH | 3/6/2024 | $0 |
| | 2024 | 2021 | INTERVENTIONAL ANALGESIX INC. | 701 W MAIN ST | DURHAM | NC | 27701-5012 | DURHAM | USA | R44NS120840 | Analgesic Drug for Local Delivery by Fluoroscopy | 000 | 2 | NIH | 9/6/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2021 | INTERVENTIONAL ANALGESIX INC. | 701 W MAIN ST | DURHAM | NC | 27701-5012 | DURHAM | USA | R44NS120840 | Analgesic Drug for Local Delivery by Fluoroscopy | 000 | 2 | NIH | 8/14/2023 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $2,558,694 ) |
| | 2021 | 2021 | INTERVENTIONAL ANALGESIX INC | 701 W MAIN ST STE 200 | DURHAM | NC | 27701-5012 | DURHAM | USA | R01NS100725 | Intraganglionic Analgesic Adeno-Associated Virus (AAV) Gene Vector Optimization in Large Animals | 004 | 5 | NIH | 7/22/2021 | $709,984 |
| | 2021 | 2021 | INTERVENTIONAL ANALGESIX INC | 701 W MAIN ST STE 200 | DURHAM | NC | 27701-5012 | DURHAM | USA | R44NS120840 | Analgesic Drug for Local Delivery by Fluoroscopy | 000 | 2 | NIH | 6/23/2021 | $1,572,160 |
| | 2021 | 2019 | INTERVENTIONAL ANALGESIX INC | 701 W MAIN ST STE 200 | DURHAM | NC | 27701-5012 | DURHAM | USA | R01NS100725 | Intraganglionic Analgesic Adeno-Associated Virus (AAV) Gene Vector Optimization in Large Animals | 003 | 3 | NIH | 2/2/2021 | $276,550 |
|
| Issue Date FY: 2020 ( Subtotal = $2,274,481 ) |
| | 2020 | 2020 | INTERVENTIONAL ANALGESIX INC | 701 W MAIN ST STE 200 | DURHAM | NC | 27701-5012 | DURHAM | USA | R44NS120840 | Analgesic Drug for Local Delivery by Fluoroscopy | 000 | 1 | NIH | 9/23/2020 | $1,586,882 |
| | 2020 | 2020 | INTERVENTIONAL ANALGESIX INC | 701 W MAIN ST STE 200 | DURHAM | NC | 27701-5012 | DURHAM | USA | R01NS100725 | Intraganglionic Analgesic Adeno-Associated Virus (AAV) Gene Vector Optimization in Large Animals | 002 | 4 | NIH | 8/11/2020 | $687,599 |
| | 2020 | 2019 | INTERVENTIONAL ANALGESIX INC | 701 W MAIN ST STE 200 | DURHAM | NC | 27701-5012 | DURHAM | USA | R43NS110272 | 2nd-Generation Spinal Analgesic Resiniferatoxin | 001 | 1 | NIH | 8/25/2020 | $0 |
| | 2020 | 2019 | INTERVENTIONAL ANALGESIX INC | 701 W MAIN ST STE 200 | DURHAM | NC | 27701-5012 | DURHAM | USA | R01NS100725 | Intraganglionic Analgesic Adeno-Associated Virus (AAV) Gene Vector Optimization in Large Animals | 000 | 3 | NIH | 7/17/2020 | $0 |
| | 2020 | 2019 | INTERVENTIONAL ANALGESIX INC | 701 W MAIN ST STE 200 | DURHAM | NC | 27701-5012 | DURHAM | USA | R43NS110272 | 2nd-Generation Spinal Analgesic Resiniferatoxin | 000 | 1 | NIH | 12/16/2019 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $707,810 ) |
| | 2019 | 2019 | INTERVENTIONAL ANALGESIX INC | 701 W MAIN ST STE 200 | DURHAM | NC | 27701-5012 | DURHAM | USA | R01NS100725 | Intraganglionic Analgesic Adeno-Associated Virus (AAV) Gene Vector Optimization in Large Animals | 001 | 3 | NIH | 9/19/2019 | $489,103 |
| | 2019 | 2019 | INTERVENTIONAL ANALGESIX INC | 221 1ST AVE SW STE 202 | ROCHESTER | MN | 55902-3125 | OLMSTED | USA | R43NS110272 | 2nd-Generation Spinal Analgesic Resiniferatoxin | 000 | 1 | NIH | 2/22/2019 | $218,707 |
|
|
